tilorone has been researched along with EHS Tumor in 1 studies
Tilorone: An antiviral agent used as its hydrochloride. It is the first recognized synthetic, low-molecular-weight compound that is an orally active interferon inducer, and is also reported to have antineoplastic and anti-inflammatory actions.
tilorone : A member of the class of fluoren-9-ones that is 9H-fluoren-9-one which is substituted by a 2-(diethylamino)ethoxy group at positions 2 and 7. It is an interferon inducer and a selective alpha7 nicotinic acetylcholine receptor (alpha7 nAChR) agonist. Its hydrochloride salt is used as an antiviral drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kavetskiĭ, RE | 1 |
| Balitskiĭ, KP | 1 |
| Veksler, IG | 1 |
| Vetrova, EP | 1 |
| Vorontsova, AL | 1 |
1 other study available for tilorone and EHS Tumor
| Article | Year |
|---|---|
[Tilorone, a synthetic immunostimulator possessing antitumor activity].
Topics: Animals; Antibody-Producing Cells; Antineoplastic Agents; Drug Evaluation, Preclinical; Fluorenes; I | 1977 |